Evidence map›Paper›PMID 26466819›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2016

Statins Reduce the Risks of Relapse to Addiction in Rats.

Claudia Chauvet, Celine Nicolas, Claire Lafay-Chebassier, Mohamed Jaber, Nathalie Thiriet, Marcello Solinas

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Hepatic, lipid and genetic factors associated with obesity: crosstalk with alcohol dependence?The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Claudia ChauvetInserm, U-1084, Experimental and Clinical Neurosciences Laboratory, University of Poitiers, Poitiers, France.
Celine NicolasInserm, U-1084, Experimental and Clinical Neurosciences Laboratory, University of Poitiers, Poitiers, France.
Claire Lafay-ChebassierInserm, U-1084, Experimental and Clinical Neurosciences Laboratory, University of Poitiers, Poitiers, France.
Mohamed JaberInserm, U-1084, Experimental and Clinical Neurosciences Laboratory, University of Poitiers, Poitiers, France.
Nathalie ThirietInserm, U-1084, Experimental and Clinical Neurosciences Laboratory, University of Poitiers, Poitiers, France.
Marcello SolinasInserm, U-1084, Experimental and Clinical Neurosciences Laboratory, University of Poitiers, Poitiers, France.ORCID http://orcid.org/0000-0002-0664-5964
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Statins are drugs that have been used for decades in humans for the treatment of hypercholesterolemia. More recently, several lines of evidence demonstrate that statins, in addition to their peripheral effects, produce a wide variety of effects in the brain and may be beneficial in neurological and psychiatric conditions. In this study, we allowed rats to self-administer cocaine for several weeks and, at the end of self-administration training, we treated them with low doses of statins daily for a 21-day period of abstinence. Chronic administration of brain-penetrating statins, simvastatin (1 mg/kg) and atorvastatin (1 mg/kg), reduced cocaine seeking compared with vehicle, whereas administration of pravastatin (2 mg/kg), a statin with low brain penetrability, did not. Importantly, the effects of brain-penetrating statins persisted even after discontinuation of the treatment and were specific for drug seeking because drug taking was not altered by simvastatin treatment. Finally, the effects of simvastatin were found to generalize to another drug of abuse such as nicotine, but not to food reward, and to reinstatement of cocaine seeking induced by stress. These results demonstrate that brain-penetrating statins can reduce risks of relapse to addiction. Given their well-known safety profile in humans, statins could be a novel effective treatment for relapse to cocaine and nicotine addiction and their use could be implemented in clinical settings without major health risks.

Indexed as

AnimalsAtorvastatinBrainCocaine-Related DisordersHydroxymethylglutaryl-CoA Reductase InhibitorsMaleRatsRats, Sprague-DawleyRecurrenceRisk FactorsSimvastatinSubstance-Related DisordersAtorvastatinHydroxymethylglutaryl-CoA Reductase InhibitorsSimvastatin

Identifiers

PMID26466819
PMCPMC4832020
OpenAlexW2315131381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.